SANTA CLARA (dpa-AFX) - Agilent Technologies, Inc. (A) and Exact Sciences
Corp. (EXAS) said on Tuesday that they have inked a deal for the sale of
Resolution Bioscience to Exact Sciences., for an undisclosed sum.

Resolution Bioscience is a developer of next-generation sequencing-based
precision oncology solutions.

Sam Raha, Senior Vice President at Agilent, said: 'Exact is a leading
centralized laboratory for advanced cancer diagnostic testing with significant
capabilities and resources in this area, which makes Resolution Bioscience a
strategic fit for them. This agreement will enable the talented Resolution
Bioscience team to continue their work advancing diagnostic solutions for their
customers and patients, a very positive outcome of this transaction.'



Copyright(c) 2023 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX